Member Info for Fruitsnveg

Doc.Dan only leaves so he can slip into one of his other characters. It's like a one-man Broadway show where all the actors are the same.

Ghia November 2023: "I don’t hold anything on the London stock exchange currently. It’s really underperforming."

Ghia Jan 2024: Must buy back in before news drops and the SP takes off. Gotta trash the SP first though.

They've sent in the Party Planner, so we must be approaching the end of this tedious line-up of fake muppet accounts soon, surely?

Ghia, Have you thought about making TFG aware of his incredible oversight in their due diligence? I'm sure they are deeply worried about the cost benefit of SNG001 being non-existent. So much so that they continued to increase their stake here AFTER Sprinter. Lolz.

Thanks for that stunning insight SpacDaneeka. Who knew you also had a strong opinion on Mankowski's appointment, - until now. Lol.

I think you are missing the point Doc.Dan, which is no doubt is intentional. To recap, it really doesn't matter WHO is doing the CMO role. The important point is that Synairgen hired a CMO to start in November 2023. They have a plan, and in that plan will be a number dependencies, which require a fulltime CMO, to be involved from certain date. It is a crucial full-time role at this point. There will be many activities both concurrent and dependent, which even if you don't know what they are, rest assured that they are happening now Mankowski has been brought in at 100% capacity. Those activities don't need your blessing to happen., they will be being done regardless of your yelping here.

TP,

If all the comments posted here by invested LTHs are "not currently relevant to my Synairgen investment", why post here everyday? What does that serve you?

I see you are triggered by the mere mention of Mankowski, Doc. Dan.

We must be getting warm!

No Aether. I think you're mixing us up with the other muppets. I believe they occupy an apartment in the basement of 123 Sesame Street from where they pen their deranged posts on a shared typewriter (with a broken ribbon).

I see Mankowsk'i hire as the company's full-time CMO 3 months ago as the canary in this goldmine. Investors looking for a sign of things to come would view his voluntary move from position of CEO of a top CRO, to join Synairgen, at this critical juncture, as 'somewhat' of a sign. Hiring of a CMO is a time critical affair for Biotechs - hire too early and it doesn't work, too late and you're behind with Regulators, key activities that the CMO is responsible for, etc. So say the various experts in the role. They did not fill that role, at that point, for fun. This is part of an orchestrated plan. Let the naysayers protest, but they cannot disagree that his hiring is significant and bodes of things to come.

Well, they may try, but.........lol.

I see Mankowsk'i hire as the company's full-time CMO 3 months ago as the canary in this goldmine. Investors looking for a sign of things to come would view his voluntary move from position of CEO of a top CRO, to join Synairgen, at this critical juncture, as 'somewhat' of a sign. Hiring of a CMO is a time critical affair for Biotechs - hire too early and it doesn't work, too late and you're behind with Regulators, key activities that the CMO is responsible for, etc. So say the various experts in the role. They did not fill that role, at that point, for fun. This is part of an orchestrated plan. Let the naysayers protest, but they cannot disagree that his hiring is significant and bodes of things to come.

Well, they may try, but.........lol.

Suggest you diarise to come back on 21st March Mani when Winter is officially over, and have your say then, if trials haven't started. Listening to your tedious "they've missed the boat" narrative Before we even reach the point of Winter's close is boring me, and probably everyone else too.

Excellent wpa, one of your finest to date.

Funny how you refer to this investment as mine, and not YOURS? What an odd thing for a so-called fellow investor to say? Are you not invested too then? Or was that some slip?

To your other point, I am interested in the facts as they pertain to my investment here. You shouldn't expect anything less of an investment forum. Even a feral cat has enough intelligence to understand the relationship between increasing rates of disease/hospitalisations and the impact/opportunity or threat that poses to our clinical testing plans in the near term, and development path in the longer term. I can see the mention of C19 now triggers you, but you need to look beyond that - hospitalisations are also being driven by RSV, flu and other respiratory viruses, as I stated below. You need to come from under that rock of yours and embrace reality, if you don't mind me saying Doc.Dan.

"U.S. Still Recording 1,500 COVID Deaths Each Week as Cases Surge Around the Globe

HEADLINEJAN 11, 2024"

https://www.democracynow.org/2024/1/11/headlines/us_still_recording_1_500_covid_deaths_each_week_as_cases_surge_around_the_globe

Posting this current headline from the US as I know Mani and Doc.Dan are very worried about a waning trialling window, but the data would seem to indicate that they should just calm down, no fear of it all suddenly going away and robbing up of our clinical studying opportunities. Hospitalisation cases are rising. Around the globe. As expected with the number of respiratory viruses circulating. Chillax ladies, chillax.

DocDan lives in a parallel universe where Covid is rapidly fading away and current variants are so weak as to barely affect most people. He cannot fathom therefore why hospitalisations due to Covid and other respiratory viruses like flu and rsv ARE RISING. A total head scratcher for our resident Dr!! He forgets that we are not targeting the healthy, nor are we silly enough to think that that who do end up in hospital (largely the immunocompromised, elderly and those who are more genetically more predisposed to the wrath of viruses than the general population) make up a small number. Over 10 million people in Britain alone are categorised as "elderly", i.e. 65 or over. Then there's the immunocompromised, the people affected by the autoabs findings, etc etc. It's not hard to understand why hospitalisations are rising in respiratory virus season. I don't think I need to labour the point for most intelligent readers on here, but Dr. Daneeka, if you are reading this, today's lesson is for you.

Mani only gets paid a bonus people can be convinced to sell. What a joker.

And for Mani who has trouble comprehending the official data ..... "Weekly admissions also increased in the seven days up to 5 January with 3,984 people admitted compared to 3,731 – a 7 per cent increase."

Https://www.independent.co.uk/news/health/covid-cases-variant-juno-schools-latest-b2477113.html

"Rapid rise of global ‘Juno’ variant infections is yet another reminder ‘pandemic is far from over’, warns virologist"

Costas, do behave. Amazon started off as an online bookstore selling books. No telephone number. Just a keyboard and mouse.